Cooper Graham K

Cooper Graham K is listed in filings as Director at Kezar Life Sciences, Inc.. This profile follows SEC Form 4 activity through Jun 5, 2026, including 10 public disclosures. Recent filings connect the profile to Kezar Life Sciences, Inc. (KZR) and Beam Therapeutics Inc. (BEAM). The current snapshot covers public activity from Jun 21, 2024 to Jun 5, 2026. Reported amounts are shown as $33.5K to $59.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.